The Effect of Exercise on Recent Onset Low Back Pain in the Emergency Department
Determining the Effects of Adding Exercise to Usual Care for Recent Onset Low Back Pain in the Emergency Department: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Low back pain (LBP) is the leading contributor to years lived with disability and an important contributor to healthcare costs and time off work. Exercise is effective for chronic low back pain, but there is a lack of evidence to inform whether exercise in the emergency department is effective for people with acute (<1 week) low back pain.
The objectives of this randomized controlled trial are:
- To determine the effectiveness of an exercise intervention delivered in the ED in comparison to usual ED care on pain, function, global rating of change, patient satisfaction, and adverse effects in adults with recent onset LBP (< 1 week).
- To determine the feasibility of a future RCT to evaluate the effects of the ED exercise intervention on return to work outcomes, health care utilization, and cost-effectiveness in comparison to usual care.
The investigators hypothesize that an exercise intervention in the ED will improve pain, function, global rating of change, and patient satisfaction in comparison to usual ED care with no difference in adverse effects.
Design: A randomized controlled trial (RCT) with two parallel arms (exercise and usual care).
Blinding: The patient will be partially blinded by our not providing full details on the two exercise approaches being studied. The health care providers delivering the interventions will not be blinded due to the nature of the intervention. However, research assistants administering the outcome measures will be blinded. The outcomes assessed are objective measures assessed using an online survey tool that will be free of assessor bias.
Randomization and allocation concealment: Participants will be randomized in a 1:1 ratio to exercise or usual care groups by an independent statistician using a computerized random number generator. The random allocation will be placed in sequentially numbered opaque envelopes. The envelopes will be opened by the RA after completion of baseline assessment.
Patient enrollment: Consecutive patients with acute LBP who are seeking urgent care at Kingston General Hospital Emergency Department (ED) and Hotel Dieu Hospital Urgent Care Clinic (UCC) will be invited to participate over a 4-month period May 1 through August 31, 2018). ED based research staff will screen patients for willingness to be invited to participate when they arrive at the ED. These staff will then invite participation once the physician assessment is complete and eligibility criteria are reviewed.
Inclusion criteria: English speaking adults (18-65 years) with recent onset LBP (<1 week).
Exclusion criteria: people with subacute/chronic LBP, previous episode of back pain in the past 3 months, fracture, previous back surgery, red flags (e.g. urinary retention, bilateral or multilevel neurological impairment), traumatic mechanism of injury (fall >3m or 3 steps, MVC >100km/h).
Assessment and outcome measures: All measures will be collected using Qualtrics, a secure online database, at baseline, 48-72 hours, 1-week, 1-month, and 3-months.
Baseline factors used to describe the population: age, gender, duration of back pain (hours), whether there have been previous episodes of back pain, whether or not the participant has pain in other areas of the body, medications, comorbidities, work status prior to onset of back pain, and current work status.
Objective #1: Individual health outcomes will be collected using validated tools described under the outcomes assessed.
Objective #2: This study design will not have adequate power or long-term follow-ups required to adequately evaluate return to work, healthcare use, and cost-effectiveness. The investigators plan to pilot the use of these outcomes to determine the feasibility of conducting a future trial to evaluate these outcomes.
Analysis: For objective #1, Repeated-measure linear mixed models will be used to assess the effect of treatment (exercise versus usual care) on our primary (disability) and secondary (pain, global rating of change, patient satisfaction, adverse effects) outcomes at all time-points (48-72 hours, 1-week, 1- and 3-months). A difference of 2 on the NPRS36 and 3 points on the RMDQ37 will be considered clinically meaningful. For objective #2, all feasibility outcomes will be reported descriptively and analyzed qualitatively as recommended by methods and reporting guidelines for pilot and feasibility studies.
Sample size: The investigators searched one year of ED and UCC records to identify LBP patients eligible for this study. 2000 patients/year attended for back pain with > 500 during our four-month recruitment period. Of these, a chart review suggests 43% of these met our eligibility criteria. Based on past trials in these settings, we expect at least 50% will consent resulting in a sample size of 107+. This will achieve over 90% power to detect a minimally important difference of 3 points on the RMQ, using a two-sided α=0.05 and assuming a standard deviation of 6.2 points and accounting for a 10% loss to follow-up. This will also provide an adequate sample to assess the secondary feasibility objectives.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 3N6
- Kingston Health Sciences Center - Kingston General Hospital and Hotel Dieu Hospital Sites
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English speaking
- Adults (18-65 years)
- Recent onset low back pain (<1 week)
Exclusion Criteria:
- Subacute/chronic LBP (> 1week)
- Previous episode of low back pain in past 3 months
- fracture
- previous back surgery
- urinary retention
- saddle anaesthesia
- bilateral or multilevel neurological impairment
- traumatic mechanism of injury (fall >3m or 3 steps, MVC >100km/h).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise
Participants in the exercise intervention arm will receive the usual care protocol plus a standardized, evidence informed exercise intervention provided by trained physiotherapy students.
The exercise intervention will begin with a brief assessment to rule out contraindications to exercise and to identify any directional preferences (e.g.
pain with lumbar flexion and relief with extension).
The PT will then be taught four standardized exercises: the pelvic tilt exercise, a rotational exercise, a tailored graded walking program taking into account the current abilities of the patient, and an exercise based on the directional preference of the individual.
These will be re-enforced with a handout including the rationale, instructions and dosage recommendations for the exercises.
|
A standardized exercise program tailored to the individual based on their directional preferences and current functional abilities.
Participants will be advised that staying physically active and continuing to participate in usual activities improves recovery.
This verbal advice will be reinforced with a written handout.
Participants will be advised on the appropriate use of ice or heat to manage pain.
This verbal advice will be reinforced with a written handout.
Participants will receive education regarding the use of non-steroidal anti-inflammatory medications (NSAIDs) for pain relief, if needed and if the patient is appropriate for NSAIDs.
Information regarding specific recommended doses, potential benefit and risk will be discussed.
|
|
Active Comparator: Usual care
Our usual care protocol was developed based on 30 responses to an 18 item survey of Queen's Department of Emergency Medicine physicians.
Three themes emerged as interventions most commonly used.
Each of these strategies has evidence for small, but positive treatment effects and low risk of harms: 1) advice to stay active and engaged in usual activities, 2) use of ice or heat to manage pain, and 3) recommendation for analgesia using NSAIDs if needed and appropriate.
|
Participants will be advised that staying physically active and continuing to participate in usual activities improves recovery.
This verbal advice will be reinforced with a written handout.
Participants will be advised on the appropriate use of ice or heat to manage pain.
This verbal advice will be reinforced with a written handout.
Participants will receive education regarding the use of non-steroidal anti-inflammatory medications (NSAIDs) for pain relief, if needed and if the patient is appropriate for NSAIDs.
Information regarding specific recommended doses, potential benefit and risk will be discussed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported disability
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Roland Morris Questionnaire (0-24, higher represents greater disability)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity currently
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Numeric pain rating scale (0-10, higher represents greater pain intensity)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
|
Pain intensity on average over past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Numeric pain rating scale (0-10, higher represents greater pain intensity)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
|
Pain intensity at its worst over the past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Numeric pain rating scale (0-10, higher represents greater pain intensity)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
|
Pain intensity at its least over the past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
Numeric pain rating scale (0-10, higher represents greater pain intensity)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
|
|
Global rating of change
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
|
Perceived change in function (-5 to +5, higher represents greater improvement in function)
|
1-week, 1-month, 3-months with a primary comparison at 1-week
|
|
Patient satisfaction
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
|
Satisfaction with healthcare received (-5 to +5, higher represents greater satisfaction with care)
|
1-week, 1-month, 3-months with a primary comparison at 1-week
|
|
Adverse effects
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
|
Self-reported adverse effects of treatment
|
1-week, 1-month, 3-months with a primary comparison at 1-week
|
|
Treatment fidelity
Time Frame: At initial visit
|
A fidelity checklist performed by the physiotherapy students carrying out the intervention will be included as a process outcome.
|
At initial visit
|
|
Recruitment rate (to determine feasibility for future trial on healthcare utilization, cost-effectiveness and return to work)
Time Frame: Recruitment rate over 4 month period
|
Rate of recruitment (number of participants/week over recruitment period)
|
Recruitment rate over 4 month period
|
|
Retention rate (to determine feasibility for future trial)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 3-month follow-up
|
Rate of assessment completion
|
Baseline, 1-week, 1-month, 3-months with a primary time-point of 3-month follow-up
|
|
Work status - working or not working (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
Work status (working/not working)
|
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
|
Work status - full or part time (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
Work status (full/part-time)
|
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
|
Work status - full or modified duties/hours(piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
Work status - full/modified duties or hours
|
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
|
Work status - hours worked (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
Number of hours worked in past seven days.
|
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
|
|
Healthcare utilization (piloted to determine the feasibility of conducting a future trial evaluating healthcare utilization)
Time Frame: 1-week, 1-month, 3-months with a primary time-point of 3-months
|
Self-report questoinnaire asking patient to report primary care visits, emergency room visits, hospitalizations, surgeries, consultations with other health care providers (e.g.
physiotherapists, chiropractors, physician specialists, diagnostic imaging (e.g.
x-ray, CT scan, MRI), and medication
|
1-week, 1-month, 3-months with a primary time-point of 3-months
|
|
Costs (piloted to determine the feasibility of conducting a cost-effectiveness analysis in a future trial)
Time Frame: All costs incurred between baseline and 3-month follow-up will be calculated
|
Includes all healthcare costs as well as societal costs using a human capital approach
|
All costs incurred between baseline and 3-month follow-up will be calculated
|
|
Quality of life (piloted to determine feasibility of performing cost-effectiveness analysis in a future trial)
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary time-point of 3-months
|
EuroQOL 5D-5L (0-100 with greater score indicating greater quality of life)
|
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary time-point of 3-months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jordan Miller, PhD, Queen's University
- Principal Investigator: Robert Brison, MD, Kingston Health Sciences Center and Queen's University
- Principal Investigator: Elizabeth Blackmore, MD, Kingston Health Sciences Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REH-715-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
NCT07582705CompletedLower Back Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Postural Low Back Pain | Mechanical Low Back Pain | Low Back Ache | Recurrent Low Back Pain | Lower Back Pain Chronic
-
NCT06552962CompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural
-
NCT05616702RecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back Pain
-
NCT04216810CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior Compartment
-
NCT07030816CompletedChronic Low Back Pain | Non-specific Low Back Pain | Low Back Pain (LBP)
-
NCT04554563CompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, Postural
-
NCT03597191CompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back Pain
-
NCT02037763UnknownChronic Low Back Pain | Acute Low Back Pain
-
NCT01539863CompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back Pain
-
NCT02985671Unknown
Clinical Trials on Exercise
-
NCT01939769TerminatedTraumatic Brain Injury
-
NCT06105788RecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain Syndrome
-
NCT07137611CompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNF
-
NCT01759342Completed
-
NCT06378762Active, not recruiting
-
NCT04135339CompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point Pain
-
NCT01170598CompletedAcute Myeloid Leukemia
-
NCT06398496RecruitingDepressive Disorder, Major
-
NCT05871775Recruiting